Ignite Creation Date:
2025-12-24 @ 3:31 PM
Ignite Modification Date:
2025-12-28 @ 2:01 PM
Study NCT ID:
NCT01770392
Status:
COMPLETED
Last Update Posted:
2014-11-27
First Post:
2013-01-15
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Relative Bioavailability of a Single Dose of Nintedanib Given Alone and in Combination With Multiple Doses of Rifampicin
Sponsor:
Boehringer Ingelheim
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2013-01
Start Date Type:
None
Primary Completion Date:
2013-03
Primary Completion Date Type:
ACTUAL
Completion Date:
2013-03
Completion Date Type:
ACTUAL
First Submit Date:
2013-01-15
First Submit QC Date:
None
Study First Post Date:
2013-01-17
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2014-11-14
Results First Submit QC Date:
None
Results First Post Date:
2014-11-27
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2014-11-26
Last Update Post Date:
2014-11-27
Last Update Post Date Type:
ESTIMATED